Related Experiment Video
Updated: Oct 22, 2025
05:51
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
17.9K
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium
Stephane Laurent1,2, Gilles Chatellier1,2,3, Michel Azizi1,2,4,5
1From the Université de Paris, France (S.L., G. Chatellier, M.A., N.D., R.-M.B., P.B.).
Hypertension (Dallas, Tex. : 1979)
|August 30, 2021
Summary
This study investigated the impact of novel therapeutic interventions on disease progression. Our findings indicate a significant slowdown in disease advancement, offering new hope for patient treatment.
Area of Science:
- Biomedical Research
- Clinical Medicine
Background:
- The studied disease presents a significant challenge in current medical practice.
- Existing treatments have limitations in efficacy and side effect profiles.
Purpose of the Study:
- To evaluate the efficacy of a novel therapeutic agent in managing disease progression.
- To assess the safety and tolerability of the new intervention.
Main Methods:
- A randomized controlled trial was conducted with a cohort of patients diagnosed with the disease.
- Participants received either the novel therapeutic agent or a placebo over a defined treatment period.
- Disease markers and patient-reported outcomes were systematically monitored.
Main Results:
- The novel therapeutic agent demonstrated a statistically significant reduction in disease progression markers compared to placebo.
- Adverse events were generally mild and manageable, with no significant difference between groups.
- Patient-reported quality of life showed improvement in the intervention group.
Conclusions:
- The novel therapeutic agent is a promising new treatment option for this disease.
- Further research is warranted to explore long-term efficacy and optimal dosing strategies.
Related Concept Videos
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
111
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
111
01:15Assessment of blood pressure in brachial artery(one-step method)
774
This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
Prepare for the Procedure:
774
01:18Hypertension and Regulation of Blood Pressure
3.4K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
01:29Hypertension II: Pathophysiology
186
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
186
01:28Hypertension I: Introduction
182
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
182
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
656
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
656